|
1
|
Costa MA: The endocrine function of human
placenta: An overview. Reprod Biomed Online. 32:14–43. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pepe GJ and Albrecht ED: Actions of
placental and fetal adrenal steroid hormones in primate pregnancy.
Endocr Rev. 16:608–648. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Whitaker-Azmitia PM, Lobel M and Moyer A:
Low maternal progesterone may contribute to both obstetrical
complications and autism. Med Hypotheses. 82:313–318. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gürbüz B, Yalti S, Ozden S and Ficicioglu
C: High basal estradiol level and FSH/LH ratio in unexplained
recurrent pregnancy loss. Arch Gynecol Obstet. 270:37–39. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
van Kruchten M, van der Marel P, de Munck
L, Hollema H, Arts H, Timmer-Bosscha H, de Vries E, Hospers G and
Reyners A: Hormone receptors as a marker of poor survival in
epithelial ovarian cancer. Gynecol Oncol. 138:634–639. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lønning PE: Poor-prognosis estrogen
receptor-positive disease: Present and future clinical solutions.
Ther Adv Med Oncol. 4:127–137. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
García-Cruz E, Piqueras M, Huguet J, Peri
L, Izquierdo L, Musquera M, Franco A, Alvarez-Vijande R, Ribal MJ
and Alcaraz A: Low testosterone levels are related to poor
prognosis factors in men with prostate cancer prior to treatment.
BJU Int. 110:E541–E546. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma CX, Bose R and Ellis MJ: Prognostic and
predictive biomarkers of endocrine responsiveness for estrogen
receptor positive breast cancer. Adv Exp Med Biol. 882:125–154.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Abdelbaset-Ismail A, Pedziwiatr D,
Schneider G, Niklinski J, Charkiewicz R, Moniuszko M, Kucia M and
Ratajczak MZ: Pituitary sex hormones enhance the pro metastatic
potential of human lung cancer cells by downregulating the
intracellular expression of heme oxygenase 1. Int J Oncol.
50:317–328. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Poniewierska-Baran A, Schneider G, Sun W,
Abdelbaset-Ismail A, Barr FG and Ratajczak MZ: Human
rhabdomyosarcoma cells express functional pituitary and gonadal sex
hormone receptors: Therapeutic implications. Int J Oncol.
48:1815–1824. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Abdelbaset-Ismail A, Borkowska S,
Janowska-Wieczorek A, Tonn T, Rodriguez C, Moniuszko M, Bolkun L,
Koloczko J, Eljaszewicz A, Ratajczak J, et al: Novel evidence that
pituitary gonadotropins directly stimulate human leukemic
cells-studies of myeloid cell lines and primary patient AML and CML
cells. Oncotarget. 7:3033–3046. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Donovan PJ and Gearhart J: The end of the
beginning for pluripotent stem cells. Nature. 414:92–97. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Otte J, Wruck W and Adjaye J: New insights
into human primordial germ cells and early embryonic development
from single-cell analysis. FEBS Lett. 591:2226–2240. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Aflatoonian B and Moore H: Germ cells from
mouse and human embryonic stem cells. Reproduction. 132:699–707.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kucia M, Halasa M, Wysoczynski M,
Baskiewicz-Masiuk M, Moldenhawer S, Zuba-Surma E, Czajka R,
Wojakowski W, Machalinski B and Ratajczak MZ: Morphological and
molecular characterization of novel population of CXCR4+ SSEA-4+
Oct-4+ very small embryonic-like cells purified from human cord
blood: Preliminary report. Leukemia. 21:297–303. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ratajczak MZ, Shin DM, Liu R, Marlicz W,
Tarnowski M, Ratajczak J and Kucia M: Epiblast/germ line hypothesis
of cancer development revisited: Lesson from the presence of Oct-4+
cells in adult tissues. Stem Cell Rev. 6:307–316. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ratajczak MZ, Schneider G, Sellers ZP,
Kucia M and Kakar SS: The embryonic rest hypothesis of cancer
development - an old XIX century theory revisited. J Cancer Stem
Cell Res. 2:e10012014.
|
|
18
|
Virchow R: Editorial Archive fuer
pathologische. Anatomie und Physiologie fuer klinische Medizin.
8:23–54. 1855.(In German).
|
|
19
|
Conheim J: Congenitales, quergestreiftes
muskelsarkon der nireren. Virchows Arch. 65:64–69. 1875.(In
German). View Article : Google Scholar
|
|
20
|
Mierzejewska K, Borkowska S, Suszynska E,
Suszynska M, Poniewierska-Baran A, Maj M, Pedziwiatr D, Adamiak M,
Abdel-Latif A, Kakar SS, et al: Hematopoietic stem/progenitor cells
express several functional sex hormone receptors-novel evidence for
a potential developmental link between hematopoiesis and primordial
germ cells. Stem Cells Dev. 24:927–937. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Abdelbaset-Ismail A, Suszynska M,
Borkowska S, Adamiak M, Ratajczak J, Kucia M and Ratajczak MZ:
Human haematopoietic stem/progenitor cells express several
functional sex hormone receptors. J Cell Mol Med. 20:134–146. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Patel H and Bhartiya D: Testicular stem
cells express follicle-stimulating hormone receptors and are
directly modulated by FSH. Reprod Sci. 23:1493–1508. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Patel H, Bhartiya D, Parte S, Gunjal P,
Yedurkar S and Bhatt M: Follicle stimulating hormone modulates
ovarian stem cells through alternately spliced receptor variant
FSH-R3. J Ovarian Res. 6:522013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shaikh A, Anand S, Kapoor S, Ganguly R and
Bhartiya D: Mouse bone marrow VSELs exhibit differentiation into
three embryonic germ lineages and germ & hematopoietic cells in
culture. Stem Cell Rev. 13:202–216. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ratajczak MZ, Bartke A and Darzynkiewicz
Z: Prolonged growth hormone/insulin/insulin-like growth factor
nutrient response signaling pathway as a silent killer of stem
cells and a culprit in aging. Stem Cell Rev. 13:443–453. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sellers ZP, Schneider G, Bujko K,
Suszynska M and Pedziwiatr D: Do cancer cell lines have fixed or
fluctuating stem cell phenotypes? - studies with the NTera2 cell
line. Stem Cell Rev. 13:603–610. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schneider G, Glaser T, Lameu C,
Abdelbaset-Ismail A, Sellers ZP, Moniuszko M, Ulrich H and
Ratajczak MZ: Extracellular nucleotides as novel, underappreciated
pro-metastatic factors that stimulate purinergic signaling in human
lung cancer cells. Mol Cancer. 14:2012015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gertler A, Bignon C, Staten NR, Sakal E,
Tchelet A, Krivi GG and Djiane J: Proceedings of the Society for
Experimental Biology and Medicine: Interaction of lactogenic
hormones with the soluble extracellular domain of prolactin
receptors. Proc Soc Exp Biol Med. 206:pp. 273–279. 1994; View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fischbach F and Dunning MB: A Manual of
Laboratory and Diagnostic Tests. 9th. Wolters Kluwer
Health/Lippincott Williams & Wilkins; Philadelphia: 2014
|
|
30
|
Araujo AB and Wittert GA: Endocrinology of
the aging male. Best Pract Res Clin Endocrinol Metab. 25:303–319.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Limpaphayom K, Taechakraichana N and
Kittinunvorakoon C: Serum estradiol and gonadotropins level in
postmenopausal women with or without hormone replacement. J Med
Assoc Thai. 80:147–152. 1997.PubMed/NCBI
|
|
32
|
Androutsos G, Karamanou M, Stamboulis E,
Tsoucalas G, Kousoulis AA and Mandelenaki D: Joseph-Claude-Anthelme
Récamier (1774–1852): Forerunner in surgical oncology. J BUON.
16:572–576. 2011.PubMed/NCBI
|
|
33
|
Remak R: Ein beitrag zur
entwickelungsgeschichte der krebshaften geschwulste Deut Klin.
6:70–174. 1854.(In German).
|
|
34
|
Durante F: Arch. Memori ed Osservazioni di
Chirugia Practica. 11:217–226. 1874.(In Italian).
|
|
35
|
Jiang Y, Jahagirdar BN, Reinhardt RL,
Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund
T, Blackstad M, et al: Pluripotency of mesenchymal stem cells
derived from adult marrow. Nature. 418:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
D'Ippolito G, Diabira S, Howard GA, Menei
P, Roos BA and Schiller PC: Marrow-isolated adult multilineage
inducible (MIAMI) cells, a unique population of postnatal young and
old human cells with extensive expansion and differentiation
potential. J Cell Sci. 117:2971–2981. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Beltrami AP, Cesselli D, Bergamin N,
Marcon P, Rigo S, Puppato E, D'Aurizio F, Verardo R, Piazza S,
Pignatelli A, et al: Multipotent cells can be generated in vitro
from several adult human organs (heart, liver, and bone marrow).
Blood. 110:3438–3446. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Goldenberg-Cohen N, Avraham-Lubin BC,
Sadikov T, Goldstein RS and Askenasy N: Primitive stem cells
derived from bone marrow express glial and neuronal markers and
support revascularization in injured retina exposed to ischemic and
mechanical damage. Stem Cells Dev. 21:1488–1500. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vacanti MP, Roy A, Cortiella J, Bonassar L
and Vacanti CA: Identification and initial characterization of
spore-like cells in adult mammals. J Cell Biochem. 80:455–460.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Howell JC, Lee WH, Morrison P, Zhong J,
Yoder MC and Srour EF: Pluripotent stem cells identified in
multiple murine tissues. Ann NY Acad Sci. 996:158–173. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Wakao S, Kitada M, Kuroda Y, Shigemoto T,
Matsuse D, Akashi H, Tanimura Y, Tsuchiyama K, Kikuchi T, Goda M,
et al: Multilineage-differentiating stress-enduring (Muse) cells
are a primary source of induced pluripotent stem cells in human
fibroblasts. Proc Natl Acad Sci USA. 108:pp. 9875–9880. 2011;
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Guerin CL, Rossi E, Saubamea B, Cras A,
Mignon V, Silvestre JS and Smadja DM: Human very small
embryonic-like cells support vascular maturation and therapeutic
revascularization induced by endothelial progenitor cells. Stem
Cell Rev. 13:552–560. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Golipoor Z, Mehraein F, Zafari F, Alizadeh
A, Ababzadeh S and Baazm M: Migration of bone marrow-derived very
small embryonic-like stem cells toward an injured spinal cord. Cell
J. 17:639–647. 2016.PubMed/NCBI
|
|
44
|
Bhartiya D, Shaikh A, Anand S, Patel H,
Kapoor S, Sriraman K, Parte S and Unni S: Endogenous, very small
embryonic-like stem cells: Critical review, therapeutic potential
and a look ahead. Hum Reprod Update. 23:41–76. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kassmer SH, Jin H, Zhang PX, Bruscia EM,
Heydari K, Lee JH, Kim CF, Kassmer SH and Krause DS: Very small
embryonic-like stem cells from the murine bone marrow differentiate
into epithelial cells of the lung. Stem Cells. 31:2759–2766. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ratajczak MZ, Ratajczak J, Suszynska M,
Miller DM, Kucia M and Shin DM: A novel view of the adult stem cell
compartment from the perspective of a quiescent population of very
small embryonic-like stem cells. Circ Res. 120:166–178. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Majka M, Drukala J, Lesko E, Wysoczynski
M, Jenson AB and Ratajczak MZ: SDF-1 alone and in co-operation with
HGF regulates biology of human cervical carcinoma cells. Folia
Histochem Cytobiol. 44:155–164. 2006.PubMed/NCBI
|
|
48
|
Schneider G, Sellers ZP, Bujko K, Kakar
SS, Kucia M and Ratajczak MZ: Novel pleiotropic effects of
bioactive phospholipids in human lung cancer metastasis.
Oncotarget. 8:58247–58263. 2017.PubMed/NCBI
|
|
49
|
Schneider G, Bryndza E, Poniewierska-Baran
A, Serwin K, Suszynska M, Sellers ZP, Merchant ML, Kaliappan A,
Ratajczak J, Kucia M, et al: Evidence that vitronectin is a potent
migration-enhancing factor for cancer cells chaperoned by
fibrinogen: A novel view of the metastasis of cancer cells to
low-fibrinogen lymphatics and body cavities. Oncotarget.
7:69829–69843. 2016.PubMed/NCBI
|
